Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4669)
All Articles published online
|
Feb 14, 2010 (publication date) through Mar 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bayraktar S, Bayraktar UD, Rocha-Lima CM. Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer. World J Gastroenterol 2010; 16(6): 673-682 [PMID: 20135714 DOI: 10.3748/wjg.v16.i6.673] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i6/673.htm |
| Number | Citing Articles |
| 1 |
Adrienne Grzenda, Tamas Ordog, Raul Urrutia. Polycomb and the Emerging Epigenetics of Pancreatic Cancer. Journal of Gastrointestinal Cancer 2011; 42(2): 100 doi: 10.1007/s12029-011-9262-4
|
| 2 |
Yangzom D. Bhutia, Sau Wai Hung, Bhavi Patel, Dylan Lovin, Rajgopal Govindarajan. CNT1 Expression Influences Proliferation and Chemosensitivity in Drug-Resistant Pancreatic Cancer Cells. Cancer Research 2011; 71(5): 1825 doi: 10.1158/0008-5472.CAN-10-2736
|
| 3 |
Iván Pérez-Díaz, Carolina Guzmán, Jesús Alberto Olivares-Reyes, Teresa Ramírez, Gabriela Gutierréz-Reyes, Marcia Hiriart, Guillermo Robles-Díaz. Evidence of an Intracellular Angiotensin-Generating System and Non-AT1, Non-AT2 Binding Site in a Human Pancreatic Cell Line. Pancreas 2011; 40(5): 701 doi: 10.1097/MPA.0b013e318215a891
|
| 4 |
J.M. Löhr, S.L. Haas, W.-O. Bechstein, G. Bodoky, K. Cwiertka, W. Fischbach, U.R. Fölsch, D. Jäger, D. Osinsky, J. Prausova, W.E. Schmidt, M.P. Lutz. Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial. Annals of Oncology 2012; 23(5): 1214 doi: 10.1093/annonc/mdr379
|
| 5 |
Alessandro Giardino, Roberto Girelli, Isabella Frigerio, Paolo Regi, Maurizio Cantore, Auriemma Alessandra, Annita Lusenti, Roberto Salvia, Claudio Bassi, Paolo Pederzoli. Triple approach strategy for patients with locally advanced pancreatic carcinoma. HPB 2013; 15(8): 623 doi: 10.1111/hpb.12027
|
| 6 |
Hehe Li, Zhengle Zhang, Chenggang Gao, Shihong Wu, Qingke Duan, Heshui Wu, Chunyou Wang, Qiang Shen, Tao Yin. Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0312-0
|
| 7 |
Wilfried Tröger, Danijel Galun, Marcus Reif, Agnes Schumann, Nikola Stanković, Miroslav Milićević. Quality of Life of Patients With Advanced Pancreatic Cancer During Treatment With Mistletoe. Deutsches Ärzteblatt international 2014; doi: 10.3238/arztebl.2014.0493
|
| 8 |
M Cantore, R Girelli, A Mambrini, I Frigerio, G Boz, R Salvia, A Giardino, M Orlandi, A Auriemma, C Bassi. Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. British Journal of Surgery 2012; 99(8): 1083 doi: 10.1002/bjs.8789
|
| 9 |
Stephen J. Pandol, Minoti V. Apte, Jeremy S. Wilson, Anna S. Gukovskaya, Mouad Edderkaoui. The burning question: Why is smoking a risk factor for pancreatic cancer?. Pancreatology 2012; 12(4): 344 doi: 10.1016/j.pan.2012.06.002
|
| 10 |
H.L. Kindler, D.A. Richards, L.E. Garbo, E.B. Garon, J.J. Stephenson, C.M. Rocha-Lima, H. Safran, D. Chan, D.M. Kocs, F. Galimi, J. McGreivy, S.L. Bray, Y. Hei, E.G. Feigal, E. Loh, C.S. Fuchs. A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer. Annals of Oncology 2012; 23(11): 2834 doi: 10.1093/annonc/mds142
|
| 11 |
W. Tröger, D. Galun, M. Reif, A. Schumann, N. Stanković, M. Milićević. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival. European Journal of Cancer 2013; 49(18): 3788 doi: 10.1016/j.ejca.2013.06.043
|
| 12 |
Yuanzeng Min, Joseph M. Caster, Michael J. Eblan, Andrew Z. Wang. Clinical Translation of Nanomedicine. Chemical Reviews 2015; 115(19): 11147 doi: 10.1021/acs.chemrev.5b00116
|
| 13 |
Viscum album [L.]-Extrakt (Iscador®) bei Patienten mit lokal fortgeschrittenem oder metastasiertem Pankreaskarzinom: eine randomisierte klinische Überlebenszeitstudie. Der Merkurstab 2014; 67(1): 4 doi: 10.14271/DMS-20258-DE
|
| 14 |
Ya Lim, Rajan Rajabalaya, Shirley Lee, Kushan Tennakoon, Quang-Vuong Le, Adi Idris, Ihsan Zulkipli, Natasha Keasberry, Sheba David. Parasitic Mistletoes of the Genera Scurrula and Viscum: From Bench to Bedside. Molecules 2016; 21(8): 1048 doi: 10.3390/molecules21081048
|
| 15 |
Yangzom Doma Bhutia, Sau Wai Hung, Madeline Krentz, Dimal Patel, Dylan Lovin, Radhika Manoharan, J. Michael Thomson, Rajgopal Govindarajan, Guillermo Velasco. Differential Processing of let-7a Precursors Influences RRM2 Expression and Chemosensitivity in Pancreatic Cancer: Role of LIN-28 and SET Oncoprotein. PLoS ONE 2013; 8(1): e53436 doi: 10.1371/journal.pone.0053436
|
| 16 |
Samira Fegrachi, I. Quintus Molenaar, John H. Klaessens, Marc G. Besselink, Johan A. Offerhaus, Richard van Hillegersberg. Radiofrequency ablation of the pancreas with and without intraluminal duodenal cooling in a porcine model. Journal of Surgical Research 2013; 184(2): 867 doi: 10.1016/j.jss.2013.04.068
|
| 17 |
Toshiyuki Tanahashi, Shinji Osada, Hisashi Imai, Yoshiyuki Sasaki, Takao Takahashi, Kazuya Yamaguchi, Kazuhiro Yoshida. Signal transduction of vitamin K3 for pancreas cancer therapy. Oncology Reviews 2011; 5(1): 57 doi: 10.1007/s12156-010-0068-6
|
| 18 |
Simcha Weissman, Kazuki Takakura, Guido Eibl, Stephen J. Pandol, Masayuki Saruta. The Diverse Involvement of Cigarette Smoking in Pancreatic Cancer Development and Prognosis. Pancreas 2020; 49(5): 612 doi: 10.1097/MPA.0000000000001550
|
| 19 |
Daniel Åkerberg, Daniel Ansari, Roland Andersson, Bobby Tingstedt. The Effects of Surgical Exploration on Survival of Unresectable Pancreatic Carcinoma: A Retrospective Case-Control Study. Journal of Biomedical Science and Engineering 2017; 10(01): 1 doi: 10.4236/jbise.2017.101001
|
| 20 |
Lin Li, Po Sing Leung. Use of herbal medicines and natural products: An alternative approach to overcoming the apoptotic resistance of pancreatic cancer. The International Journal of Biochemistry & Cell Biology 2014; 53: 224 doi: 10.1016/j.biocel.2014.05.021
|
| 21 |
Yuan Chen, Shao-An Xue, Shahriar Behboudi, Goran H. Mohammad, Stephen P. Pereira, Emma C. Morris.
Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients. Clinical Cancer Research 2017; 23(20): 6178 doi: 10.1158/1078-0432.CCR-17-1185
|
| 22 |
Yuan Chen, Lakshmana Ayaru, Sanju Mathew, Emma Morris, Stephen P. Pereira, Shahriar Behboudi, Zoltan Rakonczay. Expansion of Anti-Mesothelin Specific CD4+ and CD8+ T Cell Responses in Patients with Pancreatic Carcinoma. PLoS ONE 2014; 9(2): e88133 doi: 10.1371/journal.pone.0088133
|
| 23 |
Su Jin Kim, Suhwan Chang, Yangsoon Lee, Na Young Kim, Yeonsil Hwang, Hye Jin Min, Kyung-Sook Yoo, Eun Hye Park, Seokho Kim, Young-Hwa Chung, Young Woo Park, Sang Seok Koh. A PAUF-neutralizing antibody targets both carcinoma and endothelial cells to impede pancreatic tumor progression and metastasis. Biochemical and Biophysical Research Communications 2014; 454(1): 144 doi: 10.1016/j.bbrc.2014.10.056
|
| 24 |
|
| 25 |
Mekala Gunaratnam, Maria de la Fuente, Sonja M. Hampel, Alan K. Todd, Anthony P. Reszka, Andreas Schätzlein, Stephen Neidle. Targeting pancreatic cancer with a G-quadruplex ligand. Bioorganic & Medicinal Chemistry 2011; 19(23): 7151 doi: 10.1016/j.bmc.2011.09.055
|
| 26 |
Caitriona B. O'Neill, Coral L. Atoria, Eileen M. O'Reilly, Jennifer LaFemina, Martin C. Henman, Elena B. Elkin. Costs and trends in pancreatic cancer treatment. Cancer 2012; 118(20): 5132 doi: 10.1002/cncr.27490
|
| 27 |
Areej El‐Jawahri, Lara Traeger, Elyse R. Park, Joseph A. Greer, William F. Pirl, Inga T. Lennes, Vicki A. Jackson, Emily R. Gallagher, Jennifer S. Temel. Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer. Cancer 2014; 120(2): 278 doi: 10.1002/cncr.28369
|
| 28 |
Junxia Wang, Minghua Chen, Mengyan Wang, Wenxia Zhao, Conghui Zhang, Xiujun Liu, Meilian Cai, Yuhan Qiu, Tianshu Zhang, Huimin Zhou, Wuli Zhao, Shuyi Si, Rongguang Shao. The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP via ER stress in pancreatic cancer cells. Acta Pharmaceutica Sinica B 2022; 12(1): 210 doi: 10.1016/j.apsb.2021.07.004
|
| 29 |
B. Giessrigl, S. Krieger, M. Rosner, N. Huttary, P. Saiko, M. Alami, S. Messaoudi, J.-F. Peyrat, A. Maciuk, M. Gollinger, S. Kopf, E. Kazlauskas, P. Mazal, T. Szekeres, M. Hengstschlager, D. Matulis, W. Jager, G. Krupitza. Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells. Human Molecular Genetics 2012; 21(21): 4615 doi: 10.1093/hmg/dds303
|
| 30 |
S. Heeg, G. Illerhaus, O.G. Opitz. Zielgerichtete Therapie gastrointestinaler Tumoren. Der Gastroenterologe 2010; 5(5): 437 doi: 10.1007/s11377-010-0425-9
|
| 31 |
Fatima Ez-Zahra Amrati, Omer Hany Miligy Elmadbouh, Mohamed Chebaibi, Badr Soufi, Raffaele Conte, Meryem Slighoua, Asmaa Saleh, Omkulthom Al Kamaly, Aziz Drioiche, Touria Zair, Mouad Edderkaoui, Dalila Bousta. Evaluation of the toxicity of Caralluma europaea (C.E) extracts and their effects on apoptosis and chemoresistance in pancreatic cancer cells. Journal of Biomolecular Structure and Dynamics 2023; 41(17): 8517 doi: 10.1080/07391102.2022.2135595
|
| 32 |
Yiting Dong, Zikuan Song, Yuling Luo, Xuelei Ma. A new proposal of utilizing intraoperative electron radiation therapy on the surface of liver to prevent postoperative liver metastasis of pancreatic cancer. Medical Hypotheses 2019; 126: 15 doi: 10.1016/j.mehy.2019.02.050
|
| 33 |
Sau Wai Hung, Hardik Mody, Sean Marrache, Yangzom D. Bhutia, Franklin Davis, Jong Hyun Cho, Jason Zastre, Shanta Dhar, Chung K. Chu, Rajgopal Govindarajan, Irina V. Lebedeva. Pharmacological Reversal of Histone Methylation Presensitizes Pancreatic Cancer Cells to Nucleoside Drugs: In Vitro Optimization and Novel Nanoparticle Delivery Studies. PLoS ONE 2013; 8(8): e71196 doi: 10.1371/journal.pone.0071196
|
| 34 |
A Azzariti, G Bocci, L Porcelli, A Fioravanti, P Sini, G M Simone, A E Quatrale, P Chiarappa, A Mangia, S Sebastian, D Del Bufalo, M Del Tacca, A Paradiso. Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. British Journal of Cancer 2011; 104(5): 769 doi: 10.1038/bjc.2011.21
|
| 35 |
Yun-Hee Kim, Ju Young Moon, Eun-Ok Kim, Sang-Jin Lee, Se Hun Kang, Seok Ki Kim, Kyun Heo, Yusun Lee, Hana Kim, Kyung-Tae Kim, Daehong Kim, Min Sun Song, Seoung-Wook Lee, Yangsoon Lee, Sang Seok Koh, In-Hoo Kim. Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse model. Cancer Letters 2014; 344(2): 223 doi: 10.1016/j.canlet.2013.10.028
|
| 36 |
Rachel A. Kudgus, Annamaria Szabolcs, Jameel Ahmad Khan, Chad A. Walden, Joel M. Reid, J. David Robertson, Resham Bhattacharya, Priyabrata Mukherjee, Soumitro Pal. Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics. PLoS ONE 2013; 8(3): e57522 doi: 10.1371/journal.pone.0057522
|
| 37 |
Yun-Hee Kim, Ho Jin Sung, Sukyoung Kim, Eun-Ok Kim, Ji Won Lee, Ju Young Moon, Kyungho Choi, Ji-Eun Jung, Yangsoon Lee, Sang Seok Koh, Sue Goo Rhee, Kyun Heo, In-Hoo Kim. An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells. Cancer Letters 2011; 313(1): 76 doi: 10.1016/j.canlet.2011.08.027
|
| 38 |
Emine Canyilmaz, Lasif Serdar, Gonca Hanedan Uslu, Gulsen Soydemir, Zumrut Bahat, Adnan Yoney. Evaluation of Prognostic Factors and Survival Results in Pancreatic Carcinomas in Turkey. Asian Pacific Journal of Cancer Prevention 2013; 14(11): 6573 doi: 10.7314/APJCP.2013.14.11.6573
|
| 39 |
Sonja M. Hampel, Assitan Sidibe, Mekala Gunaratnam, Jean-François Riou, Stephen Neidle. Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells. Bioorganic & Medicinal Chemistry Letters 2010; 20(22): 6459 doi: 10.1016/j.bmcl.2010.09.066
|
| 40 |
Maha Yousaf, Dua Fatima, Javaria Amin, Aqsa Noureen, Muhammad Qaiser Fatmi. Discovering potential stabilizers for KRAS22RT G-quadruplex DNA: an alternative next generation approach to treat pancreatic cancer. Journal of Biomolecular Structure and Dynamics 2023; 41(21): 11957 doi: 10.1080/07391102.2023.2174188
|
| 41 |
Lin Li, Grace G.L. Yue, Clara B.S. Lau, Handong Sun, Kwok Pui Fung, Ping Chung Leung, Quanbin Han, Po Sing Leung. Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways. Toxicology and Applied Pharmacology 2012; 262(1): 80 doi: 10.1016/j.taap.2012.04.021
|
| 42 |
L. Li, S.L. Zhao, G.G.L. Yue, T.P. Wong, J.X. Pu, H.D. Sun, K.P. Fung, P.C. Leung, Q.B. Han, C.B.S. Lau, P.S. Leung. Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer. Phytomedicine 2018; 44: 56 doi: 10.1016/j.phymed.2018.03.055
|